Z-0102-2019 Class II Terminated
FDA device recall Z-0102-2019 was initiated by OriGen Biomedical, Inc. on Aug 21, 2018 and is designated Class II. Reason for recall: The catheter failed the endotoxin testing. The recall status is terminated (terminated Oct 5, 2021). Affected quantity: 106.
Recall details
- Product Type
- Devices
- Report Date
- Oct 24, 2018
- Initiation Date
- Aug 21, 2018
- Termination Date
- Oct 5, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 106
Product description
Reinforced Dual Lumen Cannula, 13Fr., REF: VV13F, Sterile EO; and ECMO Reinforced Dual Lumen Cannula, 13Fr., REF: VV13F, Sterile EO
Reason for recall
The catheter failed the endotoxin testing.
Distribution pattern
US Nationwide in the states of NY, AR, MO, NC, GA, LA, CO, AL, MA, CA, MI, TX, OH, MD, FL, TN, SC, OR, AZ, UT, RI, SD, PA, NM, CT. Foreign (OUS): United Arab Emirates, Kingdom of Saudi Arabia, New Zealand, Thailand
Code information
UDI: 00816203022059, lot N18687-1
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0102-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026